Global Needle-Free Injectors Market Research Report 2019
Table of Contents
Executive Summary
1 Needle-Free Injectors Market Overview
- 1.1 Product Overview and Scope of Needle-Free Injectors
- 1.2 Needle-Free Injectors Segment by Type
- 1.2.1 Global Needle-Free Injectors Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Liquid-based
- 1.2.3 Projectile/Depot-based
- 1.2.4 Powder-based
- 1.3 Needle-Free Injectors Segment by Application
- 1.3.1 Needle-Free Injectors Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals & Clinics
- 1.3.3 Home Care Settings
- 1.3.4 Research Laboratories
- 1.4 Global Needle-Free Injectors Market by Region
- 1.4.1 Global Needle-Free Injectors Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Needle-Free Injectors Market Size
- 1.5.1 Global Needle-Free Injectors Revenue (2014-2025)
- 1.5.2 Global Needle-Free Injectors Production (2014-2025)
2 Global Needle-Free Injectors Market Competition by Manufacturers
- 2.1 Global Needle-Free Injectors Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Needle-Free Injectors Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Needle-Free Injectors Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Needle-Free Injectors Production Sites, Area Served, Product Types
- 2.5 Needle-Free Injectors Market Competitive Situation and Trends
- 2.5.1 Needle-Free Injectors Market Concentration Rate
- 2.5.2 Needle-Free Injectors Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Needle-Free Injectors Production Market Share by Regions
- 3.1 Global Needle-Free Injectors Production Market Share by Regions
- 3.2 Global Needle-Free Injectors Revenue Market Share by Regions (2014-2019)
- 3.3 Global Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Needle-Free Injectors Production
- 3.4.1 North America Needle-Free Injectors Production Growth Rate (2014-2019)
- 3.4.2 North America Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Needle-Free Injectors Production
- 3.5.1 Europe Needle-Free Injectors Production Growth Rate (2014-2019)
- 3.5.2 Europe Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Needle-Free Injectors Production (2014-2019)
- 3.6.1 China Needle-Free Injectors Production Growth Rate (2014-2019)
- 3.6.2 China Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Needle-Free Injectors Production (2014-2019)
- 3.7.1 Japan Needle-Free Injectors Production Growth Rate (2014-2019)
- 3.7.2 Japan Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Needle-Free Injectors Consumption by Regions
- 4.1 Global Needle-Free Injectors Consumption by Regions
- 4.2 North America Needle-Free Injectors Consumption (2014-2019)
- 4.3 Europe Needle-Free Injectors Consumption (2014-2019)
- 4.4 China Needle-Free Injectors Consumption (2014-2019)
- 4.5 Japan Needle-Free Injectors Consumption (2014-2019)
5 Global Needle-Free Injectors Production, Revenue, Price Trend by Type
- 5.1 Global Needle-Free Injectors Production Market Share by Type (2014-2019)
- 5.2 Global Needle-Free Injectors Revenue Market Share by Type (2014-2019)
- 5.3 Global Needle-Free Injectors Price by Type (2014-2019)
- 5.4 Global Needle-Free Injectors Production Growth by Type (2014-2019)
6 Global Needle-Free Injectors Market Analysis by Applications
- 6.1 Global Needle-Free Injectors Consumption Market Share by Application (2014-2019)
- 6.2 Global Needle-Free Injectors Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Needle-Free Injectors Business
- 7.1 Antares Pharma
- 7.1.1 Antares Pharma Needle-Free Injectors Production Sites and Area Served
- 7.1.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.1.3 Antares Pharma Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Pharma Jet
- 7.2.1 Pharma Jet Needle-Free Injectors Production Sites and Area Served
- 7.2.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.2.3 Pharma Jet Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Bioject Medical Technologies
- 7.3.1 Bioject Medical Technologies Needle-Free Injectors Production Sites and Area Served
- 7.3.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.3.3 Bioject Medical Technologies Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Medical International Technology
- 7.4.1 Medical International Technology Needle-Free Injectors Production Sites and Area Served
- 7.4.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.4.3 Medical International Technology Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 INJEX Pharama
- 7.5.1 INJEX Pharama Needle-Free Injectors Production Sites and Area Served
- 7.5.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.5.3 INJEX Pharama Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 European Pharma Group
- 7.6.1 European Pharma Group Needle-Free Injectors Production Sites and Area Served
- 7.6.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.6.3 European Pharma Group Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 PenJet Corporation
- 7.7.1 PenJet Corporation Needle-Free Injectors Production Sites and Area Served
- 7.7.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.7.3 PenJet Corporation Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Crossject
- 7.8.1 Crossject Needle-Free Injectors Production Sites and Area Served
- 7.8.2 Needle-Free Injectors Product Introduction, Application and Specification
- 7.8.3 Crossject Needle-Free Injectors Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
8 Needle-Free Injectors Manufacturing Cost Analysis
- 8.1 Needle-Free Injectors Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Needle-Free Injectors
- 8.4 Needle-Free Injectors Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Needle-Free Injectors Distributors List
- 9.3 Needle-Free Injectors Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Needle-Free Injectors Market Forecast
- 11.1 Global Needle-Free Injectors Production, Revenue Forecast
- 11.1.1 Global Needle-Free Injectors Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Needle-Free Injectors Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Needle-Free Injectors Price and Trend Forecast (2019-2025)
- 11.2 Global Needle-Free Injectors Production Forecast by Regions (2019-2025)
- 11.2.1 North America Needle-Free Injectors Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Needle-Free Injectors Production, Revenue Forecast (2019-2025)
- 11.2.3 China Needle-Free Injectors Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Needle-Free Injectors Production, Revenue Forecast (2019-2025)
- 11.3 Global Needle-Free Injectors Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Needle-Free Injectors Consumption Forecast (2019-2025)
- 11.3.2 Europe Needle-Free Injectors Consumption Forecast (2019-2025)
- 11.3.3 China Needle-Free Injectors Consumption Forecast (2019-2025)
- 11.3.4 Japan Needle-Free Injectors Consumption Forecast (2019-2025)
- 11.4 Global Needle-Free Injectors Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Needle-Free Injectors Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Needle free injection technology (NFIT)is an extremely broad concept which include a wide range of drug delivery systems that drive drugs through the skin using any of the forces as Lorentz, Shock waves, pressure by gas or electrophoresis which propels the drug through the skin, virtually nullifying the use of hypodermic needle.
Rise in prevalence of diabetes raises the demand for needle-free insulin delivery devices. Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and growth in awareness about the benefits of needle-free injections and their application in treatment of cancer, diabetes, and other infectious diseases. However, high development costs of needle-free injection systems over traditional needle injection are likely to impede the market growth during the forecast period.
The global Needle-Free Injectors market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Needle-Free Injectors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Needle-Free Injectors market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Antares Pharma
Pharma Jet
Bioject Medical Technologies
Medical International Technology
INJEX Pharama
European Pharma Group
PenJet Corporation
Crossject
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Liquid-based
Projectile/Depot-based
Powder-based
Segment by Application
Hospitals & Clinics
Home Care Settings
Research Laboratories